ProductLife Group (PLG), Pharma IT’s parent company, has committed to setting near-term emissions reduction target through the Science Based Targets initiative. Pharma IT is excited to support efforts made across our group to reduce our environmental impact.
The Danish government’s proposal for extended working hours has raised a debate among businesses. Learn more about how we are doing things differently with our approach to flexible work.
We are a proud sponsor of the 10th annual Nordic Pharmacovigilance (PV) Day! Join us on November 16th in Copenhagen and learn about new challenges within Pharmacovigilance Regulated Activities!
Pharma IT ranked among top 16% of Global Companies in Corporate Social Responsibility (CSR) by EcoVadis.
As Pharma IT’s new Director of Drug Safety & Pharmacovigilance, Sukhjit Gill will lead and continue to expand our team of expert Consultants. Pharma IT’s Drug Safety & Pharmacovigilance team has vast experience leading and assisting drug safety operations and Pharmacovigilance.
Pharma IT is proud to announce that we have been awarded a significant framework agreement from the Danish government as part of a larger tender focused on IT Consultancy. This coveted framework agreement encompasses a range of critical IT consulting services, focusing on GxP, QA, and Laboratory systems.
We are proud to announce that we have joined the United Nations
Global Compact initiative — a voluntary leadership platform for the development, implementation
and disclosure of responsible business practices.
Pharma IT named an official Certified Veeva Services Partner – Development Cloud. This certification recognizes expertise in supporting implementions and post-implementation for Veeva’s industry-leading software solutions for the life sciences industry.
Birgitte Sloth will continue expanding her team of clinical scientists, trial managers, TMF specialists, and medical writers.
Maria Skou Andersen named Pharma IT’s Director of Veeva Services
Pharma IT announces partnership with ProductLife Group
Jakob joins hosts Ivanna and Sam to discuss the transformation of how smaller companies oversee their assets in the life sciences and the Pharma IT Biotech Accelerators.